Email this article ADVANCES IN THE STUDY OF MOLECULAR BASIS OF RESISTANCE TO NEW ANTI-TB DRUGS
- Authors: Peretokina I.V.1, Krylova L.Y.1, Antonova O.V.2, Kholina M.S.2, Gryadunov D.A.2, Nosova E.Y.1, Zimenkov D.V.2
-
Affiliations:
- Moscow Research and Clinical Center for Tuberculosis Control, Moscow
- Engelhardt Institute of Molecular Biology, Russian Academy of Sciences, Moscow
- Issue: Vol 8, No 4 (2018)
- Pages: 577
- Section: TUBERCULOSIS AND MYCOBACTERIA: MOLECULAR APPROACH
- Submitted: 11.01.2019
- Accepted: 11.01.2019
- Published: 30.12.2018
- URL: https://iimmun.ru/iimm/article/view/1034
- DOI: https://doi.org/10.15789/2220-7619-2018-4-6.40
- ID: 1034
Cite item
Full Text
Abstract
About the authors
I. V. Peretokina
Moscow Research and Clinical Center for Tuberculosis Control, Moscow
Author for correspondence.
Email: fake@neicon.ru
Россия
L. Yu. Krylova
Moscow Research and Clinical Center for Tuberculosis Control, Moscow
Email: fake@neicon.ru
Россия
O. V. Antonova
Engelhardt Institute of Molecular Biology, Russian Academy of Sciences, Moscow
Email: fake@neicon.ru
Россия
M. S. Kholina
Engelhardt Institute of Molecular Biology, Russian Academy of Sciences, Moscow
Email: fake@neicon.ru
Россия
D. A. Gryadunov
Engelhardt Institute of Molecular Biology, Russian Academy of Sciences, Moscow
Email: fake@neicon.ru
Россия
E. Yu. Nosova
Moscow Research and Clinical Center for Tuberculosis Control, Moscow
Email: fake@neicon.ru
Россия
D. V. Zimenkov
Engelhardt Institute of Molecular Biology, Russian Academy of Sciences, Moscow
Email: fake@neicon.ru
Россия
Supplementary files
СМИ зарегистрировано Федеральной службой по надзору в сфере связи, информационных технологий и массовых коммуникаций (Роскомнадзор).